Is Aurora Cannabis (TSX:ACB) Really Turning Around?

Top pot stock Aurora Cannabis (TSX:ACB)(NYSE:ACB) surged 67% on strong quarterly earnings. But is it really turning around?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

The Canadian cannabis giant Aurora Cannabis (TSX:ACB)(NYSE:ACB) reported its third-quarter earnings last week. Better-than-expected numbers sent the stock through the roof, surging almost 67% on Friday. There was a significant surge in its volume as well. Nearly 18 million shares exchanged hands against its three-month average daily volume of 1.1 million.

But is it really out of the woods? Let’s dig a little deeper.

Aurora Cannabis: Quarterly earnings sent the stock through the roof

Aurora’s quarterly numbers improved on several fronts compared to the quarter earlier. Michael Singer, Aurora’s interim CEO and chairman, said, “We are turning this ship around, and it’s a big ship,” BNN Bloomberg reported.

Aurora’s quarterly numbers were encouraging on some fronts. It reported quarterly net revenues of $76 million — an increase of 33% compared to the quarter earlier. Higher demand during the lockdowns played out well for Aurora Cannabis. Its top-line growth indeed came as a relief for investors compared to a dull second quarter. However, its revenues had more than doubled year over year in the fiscal year 2018 and 2019.

Notably, Aurora’s losses widened in the recently reported quarter. Its loss came in at $1.37 per share against a loss of $1.08 per share in the second quarter. Importantly, losses widening despite a revenue increase could bother discerned investors.

The management expects it to turn EBITDA positive in fiscal Q1 2021, which is during the July-September quarter of 2020.

Aurora’s cash burn improves

Aurora’s cash burn was another highlight in its latest quarterly release. It burned $154 million in cash in the reported quarter, almost 43% less compared to the previous quarter. This indicates that the company is on track to its transformation plan announced in February. This lower cash burn could help it become EBITDA positive in the next quarter, as management expects.

It ended the quarter with $230 million in cash. Once struggling for cash, Aurora Cannabis now looks well capitalized, and this cash could keep it going for the next several quarters.

An increasing number of retail stores, along with advanced recreational product range, should help Aurora Cannabis’s sales. Top-line expansion and consistent efforts on trimming operating expenses might turn the company profitable.

What should investors do?

Many potential investors would have overlooked Aurora Cannabis, given its recent reverse stock split. Although Aurora stock has soared approximately 80% in the last two trading days, it is still down more than 50% so far this year. That’s largely been the trend for pot stocks recently. Slower demand growth, saturated markets, and regulatory concerns have mainly hampered cannabis stocks in the last few years. The Horizons Marijuana Life Sciences Index ETF has lost almost 70% in the last 12 months.

Investors can expect excessive volatility to continue in the Aurora Cannabis stock. While the stock looks well placed compared to a few weeks ago, it looks significantly overvalued at the moment. Investors can wait for a pullback to enter. Importantly, although Aurora Cannabis looks to be turning around, I believe its widened losses, despite a revenue increase, could concern investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vineet Kulkarni has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »